Determination of Synthetic Impurities and Metabolic Products of F-ADAM, a Positron Emission Tomography Imaging Agent for Serotonin Transporter (SERT) Using HPLC-Tandem Mass Spectrometry
Open Access
- 1 January 2020
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Pharmacology & Pharmacy
- Vol. 11 (10), 282-298
- https://doi.org/10.4236/pp.2020.1110023
Abstract
A high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) analytical method was developed to determine the identity of impurities resulting from the synthesis of N,N-dimethyl-2-(2-amino-4-fluorophenylthio)benzyl-amine (F-ADAM), as well as its metabolic products by rat liver microsomes. 18F-ADAM is an important positive electron emission ligand commonly employed as a radio-imaging agent for serotonin transporter (SERT) in the brain. F-ADAM and its derivatives were separated using HPLC on a C4-phenyl column with an ammonium formate aqueous buffer/acetonitrile programmed mobile phase. Synthetic contaminants and metabolic products were identified using fragmentation spectra obtained by tandem mass spectrometry. We show that F-ADAM is unstable in methanol, and propose the use of acetonitrile to generate optimal chromatogram. A Cl-substituted species was found to be the major impurity resulting from the F-ADAM synthetic process. The metabolic products of F-ADAM by rat liver microsomes were characterized by oxidization of the sulfur moiety to sulfoxide, demethylation of the dimethylamine moiety, and oxidative defluorination/deamination. These results elucidate the by-products of F-ADAM synthetic and metabolic processes, and provide direction for the application of this imaging agent to biosystems properly.Keywords
This publication has 19 references indexed in Scilit:
- PET Imaging of Serotonin Transporters with 4-[18F]-ADAM in a Parkinsonian Rat ModelCell Transplantation, 2013
- Synthesis and comparison of 4-[18F]F-ADAM, 2-[18F]F-ADAM, N-Desmethyl-4-[18F]F-ADAM and [18F]F-AFM as serotonin transporter imaging agentsApplied Radiation and Isotopes, 2012
- Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic studyNuclear Medicine and Biology, 2012
- Recent trends in the impurity profile of pharmaceuticalsJournal of Advanced Pharmaceutical Technology & Research, 2010
- Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiographyNeuroImage, 2009
- Evolving Role of Mass Spectrometry in Drug Discovery and DevelopmentPublished by Wiley ,2008
- [11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETSynapse, 2005
- In Vitro Drug Metabolism Using Liver MicrosomesCurrent Protocols in Pharmacology, 2003
- How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?Pharmacology Biochemistry and Behavior, 2002
- Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthaseProceedings of the National Academy of Sciences of the United States of America, 2001